Starpharma ready to slip lubricated condom into market
Starpharma’s VivaGel condom is a world-first product and the only condom of its type that provides barrier protection and incorporates a proprietary anti-viral compound
Shares in Starpharma Holdings have trailed off since a spike of some 40 per cent saw them hit a 12-month high of 99¢ in July. This came on the back of news regarding conformity assessment certification for the VivaGel condom by the Australian Therapeutic Goods Administration.
At that stage, Starpharma mentioned its marketing partner, Ansell . planned to launch the VivaGel condom under the LifeStyles Dual Protect trademark in the coming months following listing on the Australian Register of Therapeutic Goods.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles